From Sizable Stake Zero: Why Agios Backer Vanished
When a big investor exits a biotech stock, it rattles the market and raises questions. This deep dive explains the 'f...
Biotech Stocks
Biotech Stocks page aggregates 6 articles covering catalysts, earnings moves, and company updates to help you spot opportunities and manage biotech investments more confidently.
72 articles
Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Reasons Viking Therapeutics Stock Could 10X If Obesity
Investors are watching Viking Therapeutics as its obesity drug candidate approaches key milestones. This article brea...
Could Vertex Stock Help Turn 100K Into 1M by 2036?
Turning $100,000 into $1 million by 2036 demands a high-growth plan and careful risk management. This article evaluat...
Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Million Arcellx Sale Follows Stock Drop as Rival Emerges
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
Novo Nordisk Stock Investors Adjust to Eli Lilly News
Novo Nordisk stock investors faced volatility after softer results and cautious guidance, but momentum around Wegovy ...
Is Viking Therapeutics Stock Really Heading Higher
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
Xenon Stock $42: What to Know Ahead of March Data Outlook
Xenon stock sits at $42 as insiders trim significant positions ahead of a pivotal March Phase 3 readout. This guide b...
Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Structure Therapeutics Stock 187% Gains: What It Means
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...
Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Related Topics
#Investing (55)
#Stock Analysis (16)
#Earnings Analysis (16)
#Stock Market News (11)
#Earnings (8)
#Stock Market (7)
#Portfolio Management (7)
#Insider Trading (7)
#Portfolio Strategy (6)
#risk-management (5)
#Hedge Funds (5)
#Investing Strategies (3)
#Investing Strategy (3)
#CRISPR (3)
#Viking Therapeutics (3)